Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Trading update

25 Nov 2015 07:00

RNS Number : 8492G
Plant Impact PLC
25 November 2015
 

For Immediate Release 25 November 2015

 

Plant Impact plc

("Plant Impact" or the "Company" and,

together with its subsidiaries, the "Group")

 

Trading update

 

Strong start to FY16 trading

 

Plant Impact plc (AIM: PIM) leads R&D in crop enhancement technology to create products that growers can rely on to increase the yield and quality of their crops. Today the Group announces a trading update for the three month period ended 31 October 2015.

 

Q1 FY16

 

The Directors are pleased to report that the Group has made a strong start to FY16. Revenue for Q1 grew to £3.7m (2014: £1.9m) and the Group continued to trade profitably.

 

Sales of the soy crop enhancement product, Veritas®, accounted for the majority of Q1 sales as the Group invoiced product to South America in advance of the 2015/16 growing season. In this 2015/16 growing season the Group will make a significant investment to support Veritas®, expanding its field tech team of agronomists in the Cerrado and Southern growing regions. In addition, a significant promotional campaign took roadshow events to 24 locations in Brazilian soy growing regions, reaching over 2000 growers.

FY16 outlook

Plant Impact made good progress during the period and is on track to deliver its objectives for the year. Soybean prices in Brazil are under pressure and the Brazilian Real is weak but continued strong performance is expected in the mid term. This confidence is due in part to the Veritas® Q1 promotional campaign and its positive grower response.

In Northern Europe, the Group is advancing discussions with distributors and expects to see results during the northern hemisphere spring season. The Group is also preparing to export initial shipments of Banzai®, Plant Impact's cocoa crop enhancement product, to West Africa in Q2.

Balanced investment in R&D is expected to advance a pipeline of new crop enhancement products in the coming year as new team members settle in and trials continue to produce encouraging results. The group has also begun evaluating the efficacy of its technologies for soy in Argentina and Paraguay.

John Brubaker, CEO of Plant Impact, commented: "Q1 of FY16 has been promising for the Group and I am pleased to announce this trading performance. A larger team is giving us a new depth of industry experience that is already making a positive impact on both our R&D and commercial capabilities. We are progressing in line with our planned strategy and are confident that this trend will continue."

 

Note: timetable for future financial reporting

 

The Group intends to simplify its financial reporting in the future by issuing announcements of half yearly and preliminary results in March and October respectively, together with two trading updates in June and December.

 

For more information please contact:

 

 

Plant Impact plc

 

David Jones, Chairman

John Brubaker, Chief Executive Officer

Ailish Tracy, Global Communications Manager

 

Tel: +44 (0) 1582 465 540

 

Peel Hunt - Nominated Adviser and Broker

 

Dan Webster

George Sellar

 

Buchanan

Charles Ryland

Sophie Cowles

Jane Glover

 

Tel: +44 (0) 207 418 8900

 

 

 

Tel: +44 (0) 207 466 5000

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIBPTMBBTBLA
Date   Source Headline
31st May 20118:30 amRNSTotal Voting Rights
24th May 20117:05 amRNS£2.05 million cash subscription by Arysta
24th May 20117:00 amRNSTrading update
6th Apr 20117:00 amRNSRule 17 disclosure
30th Mar 20118:30 amRNSHolding(s) in Company
11th Mar 20117:00 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSAppointment of new Chairman
30th Dec 20107:00 amRNSDirector/PDMR Shareholding
16th Dec 20109:50 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSHalf Yearly Report
24th Nov 201012:00 pmRNSHolding(s) in Company
18th Nov 20107:00 amRNSGrant of product registrations in Brazil
17th Nov 20107:00 amRNSDistribution and evaluation agreement
19th Oct 201010:30 amRNSHolding(s) in Company
23rd Sep 20107:00 amRNSEvaluation, Development and Distribution Agreement
26th Aug 201011:05 amRNSResult of AGM
25th Aug 20107:00 amRNSField Trials with Syngenta
12th Aug 20107:00 amRNSUpdated trial results
9th Aug 20107:00 amRNSGrant of Awards under LTIP and Share Options
5th Aug 20105:00 pmRNSPosting Annual Report and Accounts and AGM Notice
8th Jul 20102:20 pmRNSAppointment
14th Jun 20107:00 amRNSFinal Results
2nd Jun 20107:00 amRNSDistribution Agreement
29th Apr 20107:00 amRNSNotice of preliminary results and trading update
28th Apr 20107:00 amRNSField trial results
31st Mar 20103:30 pmRNSTotal Voting Rights
29th Mar 20102:46 pmRNSHolding(s) in Company
29th Mar 20102:45 pmRNSHolding(s) in Company
29th Mar 20102:30 pmRNSHolding(s) in Company
12th Mar 201011:15 amRNSResult of General Meeting
25th Feb 20107:00 amRNSIssue of Equity
8th Feb 20107:00 amRNSArysta agreement
3rd Feb 20107:00 amRNSPiNT study results
18th Jan 20107:00 amRNSFinalist at 2010 Grower of the Year Awards
6th Jan 20103:15 pmRNSDirectorate Change
6th Jan 201012:40 pmRNSChange of Adviser
7th Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200911:31 amRNSFurther Field Trial Results
22nd Oct 20097:00 amRNSAward of EU research grant
28th Sep 20097:00 amRNSTrading Statement
10th Sep 200910:36 amRNSHolding(s) in Company
10th Sep 200910:32 amRNSHolding(s) in Company
7th Sep 20098:31 amRNSNew Scientific Advisory Board Announcement
13th Aug 20098:41 amRNSSuccessful Application to Join Committee
6th Aug 20093:58 pmRNSGrant of Options
3rd Aug 20095:15 pmRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
31st Jul 200912:00 pmRNSTotal Voting Rights
30th Jul 200910:20 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.